(2 intermediate revisions by 2 users not shown) | |||
Line 54: | Line 54: | ||
migration, proliferation and differentiation. We approached the scaffold design with three | migration, proliferation and differentiation. We approached the scaffold design with three | ||
different proteins, each with properties to achieve better tissue regeneration and could | different proteins, each with properties to achieve better tissue regeneration and could | ||
− | interact with each other. This meant we needed a way to produce protein overexpression in E. | + | interact with each other. This meant we needed a way to produce protein overexpression in <i>E. |
− | coli vectors. </p> | + | coli</i> vectors. </p> |
<p> In this section the description of the constructs and background behind the constructs is | <p> In this section the description of the constructs and background behind the constructs is | ||
explained. </p> | explained. </p> | ||
Line 62: | Line 62: | ||
<ol> | <ol> | ||
<li>A collagen-like synthetic gene comprising heparin binding site of collagen type V (HepV) | <li>A collagen-like synthetic gene comprising heparin binding site of collagen type V (HepV) | ||
− | was employed. The synthetic gene for COL5A1 was optimized for codon usage in E. coli | + | was employed. The synthetic gene for COL5A1 was optimized for codon usage in <i>E. coli</i> |
Rosetta 2 (DE3), whereas illegal sequences were removed.</li> | Rosetta 2 (DE3), whereas illegal sequences were removed.</li> | ||
− | <li>The nucleotide sequence of collagen is optimized for E. coli Rosetta 2 (DE3) and cloned | + | <li>The nucleotide sequence of collagen is optimized for <i>E. coli</i> Rosetta 2 (DE3) and cloned |
into the backbone pSB1C3 that consists of a chloramphenicol resistant gene using EcoRI and | into the backbone pSB1C3 that consists of a chloramphenicol resistant gene using EcoRI and | ||
PstI restriction sites, with an inducible T7-lac promoter for the construction of the | PstI restriction sites, with an inducible T7-lac promoter for the construction of the | ||
Line 89: | Line 89: | ||
and tenascin is involved in affinity with many growth factors, specifically with Fibroblast | and tenascin is involved in affinity with many growth factors, specifically with Fibroblast | ||
Growth Factor (FGF). </li> | Growth Factor (FGF). </li> | ||
− | <li>The nucleotide sequence of TNCIII5 is optimized for E. coli BL21 DE3 and cloned into the | + | <li>The nucleotide sequence of TNCIII5 is optimized for <i>E. coli</i> BL21 DE3 and cloned into the |
backbone (pSB1C3) using EcoRI and PstI restriction sites, with an inducible T7-lac promoter | backbone (pSB1C3) using EcoRI and PstI restriction sites, with an inducible T7-lac promoter | ||
and rrnB-T1 terminator using RFC[10]. The domain was expressed by bacterial expression as | and rrnB-T1 terminator using RFC[10]. The domain was expressed by bacterial expression as | ||
Line 98: | Line 98: | ||
using I-Tasser simulator. </li> | using I-Tasser simulator. </li> | ||
</ol> | </ol> | ||
− | + | <div class="text-center"> | |
+ | <figure class="figure text-center"> | ||
+ | <img style="max-height: 70vh;" src="https://static.igem.org/mediawiki/2018/2/2b/T--TecCEM--TNCGST.png " | ||
+ | class="figure-img img-fluid rounded" alt="IMP-1"> | ||
+ | <figcaption class="figure-caption"><strong>Figure 2. Tenascin-GST construct pSB1C3 </strong></figcaption> | ||
+ | </figure> | ||
+ | </div> | ||
<h2 id="leptin">Leptin Biobrick </h2> | <h2 id="leptin">Leptin Biobrick </h2> | ||
<ol> | <ol> | ||
Line 105: | Line 111: | ||
composed by Tenascin, collagen, and heparin. Leptin protein is the product of the ob gene | composed by Tenascin, collagen, and heparin. Leptin protein is the product of the ob gene | ||
and it is found in adipocytes cells. </li> | and it is found in adipocytes cells. </li> | ||
− | <li>The coding sequence is optimized for Escherichia coli BL21 (DE3) and cloned in a pSB1C3 | + | <li>The coding sequence is optimized for <i>Escherichia coli</i> BL21 (DE3) and cloned in a pSB1C3 |
plasmid. To get the cloned sequence is necessary the implementation of EcoRI and PstI | plasmid. To get the cloned sequence is necessary the implementation of EcoRI and PstI | ||
restriction sites, that they are located in the prefix and suffix, respectively, previously | restriction sites, that they are located in the prefix and suffix, respectively, previously | ||
sintetized for the coding leptin sequence. In addition, the sequence part has an inducible | sintetized for the coding leptin sequence. In addition, the sequence part has an inducible | ||
T7-lac promoter (BBa_R0184 → BBa_K2406020) and a double terminator (B0010-B0012 → | T7-lac promoter (BBa_R0184 → BBa_K2406020) and a double terminator (B0010-B0012 → | ||
− | BBa_B0015) rrnBT1-T7TE from E. coli using RFC[10]. For its purification was used a | + | BBa_B0015) rrnBT1-T7TE from <i>E. coli</i> using RFC[10]. For its purification was used a |
C-terminal HIS tag. </li> | C-terminal HIS tag. </li> | ||
<li>A simulation in I-Tasser was used to prove the stability of the protein and also, to | <li>A simulation in I-Tasser was used to prove the stability of the protein and also, to | ||
Line 158: | Line 164: | ||
<td><a href="http://parts.igem.org/Part:BBa_K2719003">BBa_K2719003</a></td> | <td><a href="http://parts.igem.org/Part:BBa_K2719003">BBa_K2719003</a></td> | ||
<td>Tag</td> | <td>Tag</td> | ||
− | <td>GST (Optimized for E.coli BL21)</td> | + | <td>GST (Optimized for <i>E.coli</i> BL21)</td> |
<td>Karla Soto Blas</td> | <td>Karla Soto Blas</td> | ||
</tr> | </tr> | ||
Line 177: | Line 183: | ||
<td>Coding</td> | <td>Coding</td> | ||
<td>Collagen V - Like</td> | <td>Collagen V - Like</td> | ||
− | <td>Armando | + | <td>Armando Cortés Reséndiz & María José Ugarte Orozco</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 183: | Line 189: | ||
<td>Device</td> | <td>Device</td> | ||
<td>Collagen V - Like Expression Device.</td> | <td>Collagen V - Like Expression Device.</td> | ||
− | <td>Armando | + | <td>Armando Cortés Reséndiz & María José Ugarte Orozco</td> |
</tr> | </tr> | ||
<tr> | <tr> |
Latest revision as of 01:13, 18 October 2018
Parts Overview
Overview
The main aim for our project was to produce recombinant proteins that would compose our scaffold to improve cell proliferation. Throughout our literary research, we came across scaffolds, which were the ideal support that would improve cell-cell interaction, cell migration, proliferation and differentiation. We approached the scaffold design with three different proteins, each with properties to achieve better tissue regeneration and could interact with each other. This meant we needed a way to produce protein overexpression in E. coli vectors.
In this section the description of the constructs and background behind the constructs is explained.
Collagen Biobrick
- A collagen-like synthetic gene comprising heparin binding site of collagen type V (HepV) was employed. The synthetic gene for COL5A1 was optimized for codon usage in E. coli Rosetta 2 (DE3), whereas illegal sequences were removed.
- The nucleotide sequence of collagen is optimized for E. coli Rosetta 2 (DE3) and cloned into the backbone pSB1C3 that consists of a chloramphenicol resistant gene using EcoRI and PstI restriction sites, with an inducible T7-lac promoter for the construction of the BioBrick. The T7-lac promoter is extracted from plasmid pET-DEST42.
- A nucleotide sequence encoding Red Fluorescent Protein (RFP) was retrieved from iGEM database (BBa_K1323009) and cloned into pSB1C3 under an Anderson constitutive promoter (BBa_K823005) using an RFC[10] with restriction enzymes: EcoRI and PstI and used a double TAATAA stop codon. The resulting plasmid is referred to as pSB1C3-RFP-COLlikeHepV. To determine whether the sequence of the resulting gene would produce the same protein a simulation of the protein was done with I-Tasser.
Tenascin Biobrick
- The TNC domain of fibronectin type III-like repeats (TNCIII), specifically the subdomain TNCIII5 has the responsibility of the binding with heparin. This binding between heparin and tenascin is involved in affinity with many growth factors, specifically with Fibroblast Growth Factor (FGF).
- The nucleotide sequence of TNCIII5 is optimized for E. coli BL21 DE3 and cloned into the backbone (pSB1C3) using EcoRI and PstI restriction sites, with an inducible T7-lac promoter and rrnB-T1 terminator using RFC[10]. The domain was expressed by bacterial expression as GST fusion protein and use C-terminal HIS tag. The fusion protein GST was used for the stability of the domain.
- A polyproline linker was used between the TCDIII5 domain and GST in order to conserve the three-dimensional structure of the full protein and then a protein simulation was done using I-Tasser simulator.
Leptin Biobrick
- Leptin is a growth factor and is the main protein that helps in this project for skin regeneration. This is going to be encapsulated by chitosan and bound to the scaffold composed by Tenascin, collagen, and heparin. Leptin protein is the product of the ob gene and it is found in adipocytes cells.
- The coding sequence is optimized for Escherichia coli BL21 (DE3) and cloned in a pSB1C3 plasmid. To get the cloned sequence is necessary the implementation of EcoRI and PstI restriction sites, that they are located in the prefix and suffix, respectively, previously sintetized for the coding leptin sequence. In addition, the sequence part has an inducible T7-lac promoter (BBa_R0184 → BBa_K2406020) and a double terminator (B0010-B0012 → BBa_B0015) rrnBT1-T7TE from E. coli using RFC[10]. For its purification was used a C-terminal HIS tag.
- A simulation in I-Tasser was used to prove the stability of the protein and also, to observe the interaction of Leptin with chitosan, was necessary the implementation of the math model created by the iGEM-TEC CEM team.
Name | Type | Description | Designers |
---|---|---|---|
BBa_K2719000 | Tag | GST | Karla Soto Blas |
BBa_K2719001 | Coding | Tenascin Domain V | Karla Soto Blas |
BBa_K2719002 | Coding | GST + Tenascin Domain V | Karla Soto Blas |
BBa_K2719003 | Tag | GST (Optimized for E.coli BL21) | Karla Soto Blas |
BBa_K2719004 | Coding | Tenascin Fibronectin Domains (I-V) | Karla Soto Blas |
BBa_K2719005 | Device | Tenascin Domain V Expression Device | Karla Soto Blas |
BBa_K2719006 | Coding | Collagen V - Like | Armando Cortés Reséndiz & María José Ugarte Orozco |
BBa_K2719007 | Device | Collagen V - Like Expression Device. | Armando Cortés Reséndiz & María José Ugarte Orozco |
BBa_K2719008 | Coding | Leptin | Andrea Pamela Jimenez Tapia & Rodrigo Valencia Ocampo |
BBa_K2719009 | Device | Leptin Coding Device | Andrea Pamela Jimenez Tapia & Rodrigo Valencia Ocampo |
BBa_K2719010 | Coding | Leptin codiNg device with blue chromoprotein | Juan Carlos Rueda Silva & Arantxa Karam Coppola |
BBa_K2719011 | Coding | Collagen coding device with blue chromoprotein | Juan Carlos Rueda Silva & Arantxa Karam Coppola |
BBa_K2719012 | Coding | TCD5 coding device with blue chromoprotein | Juan Carlos Rueda Silva & Arantxa Karam Coppola |
BBa_K2719013 | Device | Blue Chromoprotein and RFP combined reporter | Juan Carlos Rueda Silva & Arantxa Karam Coppola |